The Society for Immunotherapy of Cancer (SITC) is pleased to present highlights of the latest advances in immunotherapy emerging from the ESMO Congress 2019 held in Barcelona, Spain. SITC CONNECT Account A SITC Cancer Immunotherapy CONNECT account is required to view past meeting highlights. ...
On August 28, 2019, leading experts presented the latest advances in cancer immunotherapy emerging from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting. The webinar summarized key studies on the following topics: Biomarkers and checkpoint inhibitors Cellular therapies...
2 attachments
The Society for Immunotherapy of Cancer (SITC) is pleased to present highlights of the latest advances in immunotherapy emerging from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago on May 31–June 4, 2019. This page will be updated as daily recaps are...
The Society for Immunotherapy of Cancer (SITC) is pleased to present highlights of the latest advances in immunotherapy emerging from the American Association for Cancer Research (AACR) Annual Meeting 2019, held in Atlanta, Georgia, USA on March 29-April 3, 2019. Daily Recaps Sunday, March...
The final session of the SITC 2017 Annual Meeting brought together leading experts in tumor immunology, applied mathematics, and theoretical physics to explore how knowledge from these disciplines can be assimilated to advance tumor immunotherapy. The goals of this cross-functional session were...
The Society for Immunotherapy of Cancer (SITC) held a one-day program " Workshop on Single Cell Techniques in Immunology and Cancer Immunotherapy" as part of its 32 nd annual meeting. The goal of this meeting was to bring together experts in the field of cancer immunotherapy to discuss...
As part of the 32 nd annual meeting of the Society for Immunotherapy of Cancer (SITC 2017), leaders from across the field of cancer immunotherapy took part in " Immuno-Oncology Biomarkers: Today’s Imperatives for Tomorrow’s Needs ," a program focused on next-generation biomarker research....
Immunotherapy represents the third important wave in the history of the systemic treatment of cancer after chemotherapy and targeted therapy and is now established as a potent and effective treatment option across several cancer types. The clinical success of anti-cytotoxic T-lymphocyte...
The Society for Immunotherapy of Cancer (SITC) is pleased to present highlights of the latest advances in immunotherapy emerging from the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago on June 1–5, 2018. This page will be updated as daily recaps are published....
Published in the Journal of Immunotherapy is a meeting report on the 2003 Workshop on Cancer Biometrics held by The International Society for Biological Therapy of Cancer. This workshop was designed to discuss the state of the art in identification of biomarkers and surrogates of tumor in...
cancer_biometrics_2003.pdf
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us